A detailed history of Westover Capital Advisors, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Westover Capital Advisors, LLC holds 20,452 shares of CORT stock, worth $1.54 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
20,452
Previous 20,667 1.04%
Holding current value
$1.54 Million
Previous $1.52 Million 12.07%
% of portfolio
0.33%
Previous 0.31%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

SELL
$67.17 - $83.9 $14,441 - $18,038
-215 Reduced 1.04%
20,452 $1.7 Million
Q2 2025

Aug 11, 2025

SELL
$62.24 - $91.93 $21,846 - $32,267
-351 Reduced 1.67%
20,667 $1.52 Million
Q1 2025

May 06, 2025

BUY
$49.85 - $114.22 $270,735 - $620,328
5,431 Added 34.84%
21,018 $2.4 Million
Q4 2024

Feb 06, 2025

BUY
$44.66 - $60.85 $20,364 - $27,747
456 Added 3.01%
15,587 $785,000
Q3 2024

Nov 08, 2024

BUY
$29.51 - $46.26 $446,515 - $699,960
15,131 New
15,131 $699,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $8.09B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Westover Capital Advisors, LLC Portfolio

Follow Westover Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westover Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Westover Capital Advisors, LLC with notifications on news.